Safety evaluation of an enzymatically-synthesized glycogen (ESG)

Regulatory Toxicology and Pharmacology

Volumn 57, Issue 2-3, 2010, Pages 210-219

  Tafazoli, Shahrzad ^a   Wong, Andrea W ^a   Kajiura, Hideki ^b,c   Kakutani, Ryo ^b   Furuyashiki, Takashi ^b   Takata, Hiroki ^b   Kuriki, Takashi ^b  

^a Cantox Health Sciences International   (Canada)

^b EZAKI GLICO CO LTD   (Japan)

^c Glico Foods Co Ltd   (Japan)

Author keywords

Acute; Dietary fiber; Enzymatically synthesized glycogen; Mutagenicity; Subchronic

Indexed keywords

GLYCOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; FEMALE; FOOD CONTAMINATION; FOOD SAFETY; HISTOPATHOLOGY; IN VITRO STUDY; MALE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT;

ACUTE TOXICITY TESTS; AMYLOSE; ANIMALS; CONSUMER PRODUCT SAFETY; DEXTRINS; DIETARY CARBOHYDRATES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FEMALE; GLYCOGEN; GLYCOGEN DEBRANCHING ENZYME SYSTEM; HUMANS; ISOAMYLASE; MALE; MUTAGENICITY TESTS; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM; TOXICITY TESTS, CHRONIC;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS; RODENTIA;

EID: 77953361600     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2010.02.009     Document Type: Article

References (32)

1. Adam A., Levrat-Verny M.A., Lopez H.W., Leuillet M., Demigné C., Rémésy C.M. Whole wheat and triticale flours with differing viscosities stimulate cecal fermentations and lower plasma and hepatic lipids in rats. J. Nutr. 2001, 131:1770-1776.
2. Al-Gindan Y., Sharwarby M., Noto A., Taylor C.G. Intestinal inflammation in rats induced metalothionein in colonic submucosa. J. Clin. Biochem. Nutr. 2009, 44(2):131-141.
3. Cori C.F., Cori G.T. Crystalline muscle phosphorylase. IV. Formation of glycogen. J. Biol. Chem. 1943, 151:57-63.
4. de Groot A.P., Til H.P., Feron V.J., Van der Meullen H.C.D., Willems M.I. Two-year feeding and multigeneration studies in rats on five chemically modified starches. Food Cosmet. Toxicol. 1974, 12:651-664.
5. Evans G.O. Leukocytes. Animal Hematotoxicology: A Practical Guide for Toxicologists and Biomedical Researchers 2009, 65-83. CRC Press/Taylor and Francis Group, Boca Raton, FL, (Chapter 6). G.O. Evans (Ed.).
6. Flamm W.G., Blackburn G.L., Comer C.P., Mayhew D.A., Stargel W.W. Long-term food consumption and body weight changes in neotame safety studies are consistent with the allometric relationship observed for other sweeteners and during dietary restrictions. Regul. Toxicol. Pharmacol. 2003, 38:144-156.
7. Fujii K., Takata H., Yanase M., Terada Y., Ohdan K., Takaha T., Okada S., Kuriki T. Bioengineering and application of novel glucose polymers. Biocatal. Biotransform. 2003, 21:167-172.
8. Furuyashiki, T., Takata, H., Kojima, I., Kajiura, H., Kuriki, T., 2007. On the dietary fiber-like effect of glycogen. In: Speech Summaries from the Congress of Japanese Society of Nutrition and Food Science, Kyoto, Japan.
9. Gatehouse D., Haworth S., Cebula T., Gocke E., Kier L., Matsushima T., Melcion C., Nohmi T., Ohta T., Venitt S., Zeiger E. Recommendations for the performance of bacterial mutation assays. Mutat. Res. 1994, 312:217-233.
10. Geddes R. Glycogen: a metabolic viewpoint. Biosci. Rep. 1986, 6:415-428.
11. Germolec D.R., Frawley R.P., Evans E. Markers of inflammation. Methods Mol. Biol. 2009, 598:53-73.
12. Hall R.L., Everds N.E. Principles of clinical pathology for toxicology studies. Principles and Methods of Toxicology 2007, 1317-1358. CRC Press, Boca Raton, FL, (Chapter 26). fifth ed. A.W. Hayes (Ed.).
13. JP, 2006. The Japanese Pharmacopoeia, 15th ed. Society of Japanese Pharmacopoeia (SJP), Japan. Available from: . http://jpdb.nihs.go.jp/jp15e/JP15.pdf.
14. Kajiura H., Kakutani R., Akiyama T., Takata H., Kuriki T. A novel enzymatic process for glycogen production. Biocatal. Biotransform. 2008, 26:133-140.
15. Kakutani R., Adachi Y., Kajiura H., Takata H., Kuriki T., Ohno N. Relationship between structure and immunostimulating activity of enzymatically synthesized glycogen. Carbohydr. Res. 2007, 342:2371-2379.
16. Levrat M.A., Behr S.R., Rémésy C., Demigné C. Effects of soybean fiber on cecal digestion in rats previously adapted to a fiber-free diet. J. Nutr. 1991, 121:672-678.
17. Lynch B.S., Tischler A.S., Capen C., Munro I.C., McGirr L.M., McClain R.M. Low digestible carbohydrates (polyols and lactose): significance of adrenal medullary proliferative lesions in the rat. Regul. Toxicol. Pharmacol. 1996, 23:256-297.
18. Mallett A.K., Bearne C.A., Young P.J., Rowland I.R., Berry C. Influence of starches of low digestibility on the rat caecal microflora. Br. J. Nutr. 1988, 60:597-604.
19. Ministry of Health and Welfare, Japan, 1997. Good Laboratory Practice Standard Ordinance for Non-Clinical Laboratory Studies on Safety of Drugs. Ministry of Health and Welfare, Tokyo, Japan. MHW Ordinance No. 21, March 26, 1997.
20. Ministry of Health, Labor and Welfare, Japan, 1999. Guideline for Genotoxicity Studies of Drugs. Ministry of Health and Welfare, Japan, Director of Evaluation and Licensing Division, Pharmaceutical and Medical Safety Bureau, Tokyo, Japan. Notification No. 1604, November 1, 1999.
21. OECD, 1998. OECD Principles of Good Laboratory Practice (as Revised in 1997). Organisation for Economic Co-Operation & Development (OECD), Environment Directorate, Chemicals Group and Management Committee, OECD Environmental Health and Safety Publications, Paris, France. OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring, No 1, ENV/MC/CHEM(98)17. Available from: . http://www.olis.oecd.org/olis/1998doc.nsf/LinkTo/env-mc-chem(98)17.
22. Ohdan K., Fujii K., Yanase M., Takaha T., Kuriki T. Enzymatic synthesis of amylose. Biocat. Biotransform. 2006, 24:77-81.
23. Okazaki H., Nishimune T., Matsuzaki H., Miura T., Morita S., Yanagimoto Y., Yamagishi H., Yamada K., Ikegami S. Increased incidence rate of colorectal tumors due to the intake of a soluble dietary fiber in rat chemical carcinogenesis can be suppressed by substituting partially an insoluble dietary fiber for the soluble one. Int. J. Cancer 2002, 100:388-394.
24. Roach P.J. Glycogen and its metabolism. Curr. Mol. Med. 2002, 2:101-120.
25. Ryoyama K., Kidachi Y., Yamaguchi H., Kajiura H., Takata H. Anti-tumor activity of an enzymatically synthesized α-1,6 branched β-1,4-glucan, glycogen. Biosci. Biotechnol. Biochem. 2004, 68:2332-2340.
26. Sacquet E., Leprince C., Riottot M. Dietary fiber and cholesterol and bile acid metabolisms in axenic (germfree) and holoxenic (conventional) rats. II. Effect of pectin. Reprod. Nutr. Dev. 1982, 22:575-581.
27. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994, 35(Suppl. 1):S35-S38.
28. Takata H., Kajiura H., Furuyashiki T., Kakutani R., Kuriki T. Fine structural properties of natural and synthetic glycogens. Carbohydr. Res. 2009, 344:654-659.
29. Tolmasky D.S., Krisman C.R. The degree of branching in (alpha 1,4)-(alpha 1,6)-linked glucopolysaccharides is dependent on intrinsic properties of the branching enzymes. Eur. J. Biochem. 1987, 168:393-397.
30. Weiss D.J. Leukocyte response to toxic injury. Toxicol Pathol 1993, 21:135.
31. WHO, 1987. Principles for the safety assessment of food additives and contaminants in food. World Health Organization (WHO), International Programme on Chemical Safety (IPCS), Geneva, Switz. Environmental Health Criteria, No 70, pp. 39-56. Available from: . http://www.inchem.org/documents/ehc/ehc/ehc70.htm.
32. Yakuji Nippo Limited, 2006. Guidebook for Manufacturing and Selling Cosmetics and Quasi Drugs. Yakuji Nippo Limited, Tokyo, Japan.